Yusuke Kamihara

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Diffuse Large B-cell Lymphoma with PKM2 and HK2 Expression Presenting with Lactic Acidosis and Hypoglycemia Consistent with the Warburg Effect.

Diffuse Large B-cell Lymphoma with PKM2 and HK2 Expression Presenting with Lactic Acidosis and Hypoglycemia Consistent with the Warburg Effect.

Journal: Internal medicine (Tokyo, Japan)

Published: June 28, 2026

Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly.

Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly.

Journal: Cureus

Published: January 22, 2026

Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial).

Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial).

Journal: Haematologica

Published: January 19, 2026

Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.

Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.

Journal: PloS one

Published: October 14, 2025

Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.

Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.

Journal: Cureus

Published: May 12, 2025

Complete response using the EZH2 inhibitor tazemetostat against multiple relapsed follicular lymphoma in the leukemic phase.

Complete response using the EZH2 inhibitor tazemetostat against multiple relapsed follicular lymphoma in the leukemic phase.

Journal: International cancer conference journal

Published: June 18, 2024

Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.

Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.

Journal: Heliyon

Published: September 21, 2023

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

Journal: Cells

Published: July 16, 2023

Simultaneous XIAP and cIAP1/2 inhibition by a dimeric SMAC mimetic AZD5582 induces apoptosis in multiple myeloma.

Simultaneous XIAP and cIAP1/2 inhibition by a dimeric SMAC mimetic AZD5582 induces apoptosis in multiple myeloma.

Journal: Journal of pharmacological sciences

Published: July 11, 2023

A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.

A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.

Journal: International journal of molecular sciences

Published: July 04, 2023

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.

Journal: Cells

Published: March 05, 2023

Involvement of activation induced cytidine deaminase in malignant B-cells expressing two distinct M-components as an etiology of biclonal gammopathy.

Involvement of activation induced cytidine deaminase in malignant B-cells expressing two distinct M-components as an etiology of biclonal gammopathy.

Journal: Medicine

Published: January 03, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026